Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/26/2012WO2012142926A1 Camptothecin compound containing stable 7-membered lactone ring, preparation method and use
10/26/2012WO2012142724A1 New low side effect pharmaceutical composition containing antituberculosis drugs
10/26/2012WO2012142669A1 A method for the treatment of a solid tumour
10/26/2012WO2012116357A3 Use of agr3 for treating cancer
10/26/2012WO2012112767A3 Collagen-targeted nanoparticles
10/26/2012WO2012111996A3 Transdermal delivery system containing galantamine or salts thereof
10/26/2012WO2012111961A3 Orally administrated sustained-release tablet containing tianeptine or pharmaceutically acceptable salt thereof
10/26/2012WO2012108738A3 Sildenafil-free base-containing film preparation and method for producing same
10/26/2012WO2012108631A3 Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
10/26/2012WO2012105794A3 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same
10/26/2012WO2012105767A3 Antiarrhythmic agent preparations having a ph-independent dissolution profile
10/26/2012WO2012104277A3 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
10/26/2012WO2012100097A3 Topical minocycline compositions and methods of using the same
10/26/2012WO2012097049A3 Dna repair enzyme inhibitor nanoparticles and uses thereof
10/26/2012WO2012096926A3 Method for delivering agents into cells using bacterial toxins
10/26/2012WO2012094679A3 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
10/26/2012WO2012094598A3 Pharmaceutical compositions of iron for oral administration
10/26/2012WO2012094283A3 Bepotastine compositions
10/26/2012WO2012092594A3 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
10/26/2012WO2012088306A3 Two-piece injectable drug delivery device with heat-cured seal
10/26/2012WO2012087823A3 Ph-induced silk fibroin gels and uses thereof
10/26/2012WO2012056387A3 A dermaceutical gel made using sodium fusidate and a process to make it
10/26/2012WO2012028525A3 Method for producing a tetranectin-apolipoprotein a-i particle, the lipid particle obtained therewith and its use
10/26/2012WO2011146876A3 Oral transmucosal administration of sufentanil
10/26/2012WO2011127064A3 Sustained-release reservoir implants for intracameral drug delivery
10/26/2012CA2833856A1 Pressure-sensitive adhesive tape package
10/26/2012CA2833633A1 Composition and method for enhancing an immune response
10/26/2012CA2833596A1 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012CA2833594A1 Liquid carrier for oral delivery of a pharmacologically active agent
10/26/2012CA2833591A1 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/26/2012CA2833574A1 Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
10/26/2012CA2833571A1 Method of drug delivery for pth, pthrp and related peptides
10/26/2012CA2833474A1 Method for producing patch, and patch
10/26/2012CA2833413A1 A method for the treatment of a solid tumour
10/26/2012CA2833369A1 Vaccine delivery method
10/26/2012CA2833326A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012CA2831650A1 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
10/25/2012US20120270949 Melt-granulated cinacalcet
10/25/2012US20120270920 Compositions and methods for treatment of pouchitis
10/25/2012US20120270903 Intranasal spray device containing pharmaceutical composition
10/25/2012US20120270895 Intranasal Opioid Compositions
10/25/2012US20120270788 Method of Administering Porcine B-Domainless fVIII
10/25/2012US20120269908 Carrier in oil-in-water emulsion form, particularly for cosmetic or dermatological use
10/25/2012US20120269897 Poly(tetrafluoroethylene) polymer with nitric oxide donating surface
10/25/2012US20120269896 Magnetic iron oxide fine particles, and magnetic particle-containing water dispersion and process for producing the same
10/25/2012US20120269895 Dendritic pic micelles with bioactive proteins
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269893 Compositions Comprising Solid Particles Encapsulated In A Cross-Linked Silicone Matrix, And Methods Of Making The Same
10/25/2012US20120269892 Implantable compositions and methods for preparing the same
10/25/2012US20120269891 Controlled release oral pharmaceutical dosage forms comprising mgbg
10/25/2012US20120269890 Process for obtaining a rosuvastatin calcium composition and obtained product
10/25/2012US20120269889 Non-gelatin soft capsule system
10/25/2012US20120269888 Barrier composition
10/25/2012US20120269887 Pomegranate fruit polyphenol composition and methods of use and manufacture thereof
10/25/2012US20120269886 Therapeutic agent for pulmonary fibrosis
10/25/2012US20120269885 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269884 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269883 MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/25/2012US20120269882 Brain Delivery of Insulin to Treat Systemic Inflammation
10/25/2012US20120269881 Transdermal drug delivery device including an occlusive backing
10/25/2012US20120269880 Purified amniotic membrane compositions and methods of use
10/25/2012US20120269879 Compositions comprising honey and a super- absorbent material
10/25/2012US20120269878 Composition For Transdermal Delivery Of Fentanyl
10/25/2012US20120269874 Compositions for topical application comprising a peroxide and retinoid
10/25/2012US20120269873 Flexible Bone Composite
10/25/2012US20120269872 Novel salt 628
10/25/2012US20120269871 Solid state forms of rasagiline salts
10/25/2012US20120269870 Switchable polymers and surfaces with reversibly switchable properties
10/25/2012US20120269869 Colon vitamin
10/25/2012US20120269868 Compositions and methods for nutritional supplementation
10/25/2012US20120269867 Methods of treating central nervous system tumors
10/25/2012US20120269866 Gastroretentive Composition On The Basis Of A Water-Soluble Reaction Product From A Vinyl Group-Containing Precursor
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269792 Eutectic-based self-nanoemulsified drug delivery system
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269740 Use of benzyloxy-ethylamine derivatives as a preservative, preservation method, and compositions
10/25/2012US20120269739 Composition, use, and preservation method
10/25/2012US20120269737 Polymer coated ferrite fine particles and method for preparing polymer coated ferrite fine particles
10/25/2012US20120269722 Chemoembolisation
10/25/2012DE102011018403A1 Verfahren zur Herstellung von pharmazeutischen Erzeugnissen aus einem Schmelzematerial Process for the preparation of pharmaceutical products from a molten material
10/24/2012EP2514760A1 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
10/24/2012EP2514477A1 Delivery devices with collimated gas stream and particle source
10/24/2012EP2514440A1 Transdermal preparation containing basic anti-inflammatory agent
10/24/2012EP2514431A1 A sea cucumber compound product, preparation method and preparation forms thereof
10/24/2012EP2514424A1 Piroxicam-containing endermic preparation
10/24/2012EP2514422A1 Elution-stabilized preparation
10/24/2012EP2514419A1 Felbinac-containing transdermal absorption preparation
10/24/2012EP2514418A1 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof
10/24/2012EP2514416A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514415A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514414A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514413A1 Controlled-Release Gliclazide Formulations
10/24/2012EP2514412A1 Highly Concentrated Insulin Solutions and Compositions
10/24/2012EP2514411A1 Needleless Transdermal Drug Delivery Devices
10/24/2012EP2514410A2 Liposome composition, preparation method thereof, and usage of the composition as pneumonia vaccine
10/24/2012EP2514409A1 Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane
10/24/2012EP2514408A1 Drug Delivery Devices and Methods with Collimated Gas Stream and Release-Activatable Tape
10/24/2012EP2514407A1 Stable non-aqueous pharmaceutical compositions
10/24/2012EP2514406A1 Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
10/24/2012EP2514374A1 Devices for delivering agents across biological barriers
1 ... 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 ... 2991